Hao Zhu, M.D.

Hao Zhu, M.D.

  • The Nancy B. and Jake L. Hamon Distinguished Chair in Therapeutic Oncology Research
  • Internal Medicine - Hematology/Oncology


Hao Zhu, M.D., received his bachelor’s degree in biology from Duke University, and earned his M.D. at Harvard Medical School and Massachusetts Institute of Technology. He received training in internal medicine at the University of California, San Francisco, and in medical oncology at the Dana-Farber Cancer Institute. From 2008 to 2012, Dr. Zhu performed postdoctoral research at Boston Children’s Hospital, where he explored connections among RNA biology, cancer, and regeneration in mouse models.

In 2012, he joined the faculty of UT Southwestern and the Children’s Medical Center Research Institute at UT Southwestern (CRI). Dr. Zhu is the director of the CRI Tissue Regeneration Program and a co-leader of the Simmons Comprehensive Cancer Center Development and Cancer Research Program. He is also an attending physician in the Multidisciplinary Liver Cancer Clinic at Parkland Memorial Hospital.

Dr. Zhu is the recipient of a Burroughs Wellcome Career Award for Medical Scientists (2012), a CPRIT Scholar Award (2012), and a Stand Up To Cancer Innovative Research Grant (2016). He also holds the Nancy B. and Jake L. Hamon Distinguished Chair in Therapeutic Oncology Research.

About the Zhu Laboratory

The Zhu laboratory is interested in understanding the relationship between injury, regeneration, and cancer. Researchers are focused on identifying the genes and mechanisms that regulate regenerative capacity in the liver and understanding how these contribute to hepatocellular carcinoma development, which is the third leading cause of cancer death in the world.

 Zhu Laboratory

Education & Training
  • Fellowship - Dana-Farber Cancer Institute (2007-2011), Hematology Oncology
  • Medical School - Harvard Medical School (2000-2005)
  • Residency - University of California, San Francisco (2005-2007), Internal Medicine
Honors & Awards
  • Member of the American Society of Clinical Investigation 2018
  • Magna cum laude and James Tolbert Shipley Prize for MD Honors Thesis, Harvard Medical School 2005
  • CPRIT Scholar in Cancer Research 2012
  • Burroughs Wellcome Fund Career Award for Medical Scientists 2012
  • SU2C Innovative Research Grant 2016-2019
Books & Publications
  • RNA biology
  • Mechanisms of organ regeneration
  • Liver cancer
  • Epigenetics

Dr. Zhu discusses his approach to patient care.

Results: 1 Locations